The blood thinners Pradaxa and Xarelto are prescribed to reduce blood clots and lower the chance of strokes in individuals using non-valvular atrial fibrillation. These anticoagulant medications are connected to uncontrollable internal bleeding and death. The lawyers of Salter Ferguson, LLC at Birmingham represent individuals nationally who were mistreated by Xarelto litigation and Pradaxa. In the event that you were hurt or if a part of your household died from using those dangerous drugs, then please contact us to discuss your case. We provide a free first consultation to answer your questions and address your concerns.
The Issue with Xarelto and Pradaxa
Medicine manufacturers developed Xarelto and Pradaxa as a new category of anticoagulant which didn’t require tracking via blood tests such as Coumadin does. Regrettably, there isn’t a reversal agent for Xarelto. Without a change agent, individuals taking Xarelto and Pradaxa are in elevated risk of severe harm or death in case of a critical bleeding episode.
Who’s at Risk of Injury from Xarelto and Pradaxa?
Anyone who chooses Xarelto or even Pradaxa is in danger of a uncontrollable bleeding occasion. Elderly people and people who have liver or kidney disease are at greater risk. Their bodies might be not able to clear the drug in their own systems. Lawyers Karen Salter and Carmen Ferguson are experienced in managing complicated cases against pharmaceutical companies and their insurers. Along with being a attorney, Ms. Salter is a registered nurse.
Her medical understanding benefits customers harmed by harmful medications such as Xarelto and Pradaxa. Ms. Ferguson is a former insurance company that knows how insurance businesses operate to lessen the quantity of financial reimbursement injured men and women receive.
How We Can Assist You Seek Payment for Xarelto & Pradaxa Injuries
You can depend on our legal staff for successful legal representation and personal service throughout your circumstance. We’ll clarify your scenario in plain English, not legalese. We’ll return your telephone calls and emails immediately. We’ll treat you as we would a member of their family using a legal issue. To find out more about Xarelto and Pradaxa dangerous medications lawsuit and discover out in the event that you’ve got a circumstance, please contact us on the internet. We represent clients on a contingency basis. This means you’ll pay nothing up front and nothing out of pocket. Our legal penalties come as a proportion of whatever reimbursement we acquire for you. When there’s absolutely no financial recovery, you’ll pay no legal fees in any way. From our office in Birmingham we represent individuals injured by Xarelto and Pradaxa and other faulty products nationally.
Can Pradaxa MDL Settlement Serve As Precedent?
This legal terrain isn’t entirely uncharted. In reality, a strikingly-similar lawsuit frees around the first new generation anticoagulant introduced to compete with warfarin: Pradaxa. Produced and marketed by Boeringher Ingelheim, a German company, Pradaxa struck on the marketplace and immediately became a blockbuster. Much like Xarelto, the medication was released with no antidote. Patients soon started to step ahead, the New York Times reports, submitting personal injury lawsuits within acute bleeding events.
Are Patients Filing Xarelto Lawsuits?
While most blood thinners demand a risk of bleeding, conventional medicines arrive equipped with powerful and swift change agents. The anticoagulant effects of warfarin, by way of instance, can be reversed with a shot of donor blood plasma or vitamin K. That is a literal life-saver for individuals that suffer traumatic injuries or undergo internal bleeding. Xarelto, on the other hand, was introduced to the marketplace with no known antidote. Some patients claim that this absence of an antidote leaves Xarelto faulty. Their argument is that Xarelto has to be considered very harmful, because its consequences can’t be reversed. Additionally, plaintiffs have accused Janssen Pharmaceutical, together with its parent firm Bayer, of failing to adequately warn the medical community about Xarelto’s potential dangers, including the lack of an accessible reversal agent.